<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2021-7-2-0-8</article-id><article-id pub-id-type="publisher-id">2392</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine (miscellaneous)</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Changes in the blood complement system in the development of diabetic retinopathy in the elderly&lt;/strong&gt;&lt;br /&gt;
&amp;nbsp;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Changes in the blood complement system in the development of diabetic retinopathy in the elderly&lt;/strong&gt;&lt;br /&gt;
&amp;nbsp;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Agarkov</surname><given-names>Nikolai M.</given-names></name><name xml:lang="en"><surname>Agarkov</surname><given-names>Nikolai M.</given-names></name></name-alternatives><email>vitalaxen@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Gorko</surname><given-names>Tatyana S.</given-names></name><name xml:lang="en"><surname>Gorko</surname><given-names>Tatyana S.</given-names></name></name-alternatives><email>mntk@mntk-tambov.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Lev</surname><given-names>Inna V.</given-names></name><name xml:lang="en"><surname>Lev</surname><given-names>Inna V.</given-names></name></name-alternatives><email>michina.inna@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Shekaturov</surname><given-names>Alexey A.</given-names></name><name xml:lang="en"><surname>Shekaturov</surname><given-names>Alexey A.</given-names></name></name-alternatives><email>Irkc@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Shabalin</surname><given-names>Aleksey A.</given-names></name><name xml:lang="en"><surname>Shabalin</surname><given-names>Aleksey A.</given-names></name></name-alternatives><email>cap2609@mail.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2021</year></pub-date><volume>7</volume><issue>2</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2021/2/Биомед_июнь-68-75.pdf" /><abstract xml:lang="ru"><p>Background: In the elderly, diabetic retinopathy causes a significant deterioration in the functional activity and quality of life of patients, but the individual mechanisms of its development and, in particular, the influence of the components of the blood complement system remain insufficiently studied. The aim of the study: To analyze the features of the blood complement system in elderly patients with diabetic retinopathy. Materials and methods: The components of the blood complement system were studied in 78 patients aged 60-74 years with diabetic retinopathy (the main group) at the Tambov branch of the Academician S. N. Fedorov Eye Microsurgery Research Institute by means of an enzyme immunoassay and a hemolytic method using a commercial ELISA kit (UK). The control group consisted of 46 patients aged 60-74 years without diabetic retinopathy, in whom the blood complement system was similarly examined. To identify the leading components of the blood complement system that contribute to the development of diabetic. Results: In elderly patients with diabetic retinopathy, there was a significant and statistically significant increase in serum C3a components of the complement system to 145.9&amp;plusmn;4.3 ng/ml versus 43.1&amp;plusmn;3.8 ng/ml in the control group, C5a components to 6.8&amp;plusmn;0.4 ng/ml versus 3.2&amp;plusmn;0.2 ng/ml, respectively, factor H to 262.3&amp;plusmn;5.0 mcg/ml versus 139.8&amp;plusmn;4.1 mcg/ml. Simultaneously, with the development of diabetic retinopathy, a decrease in C1-ing components was observed. In accordance with the values of the odds ratio, the leading components of the blood complement system that determine the formation of diabetic retinopathy in old age are the C3a component, C5a component, and the H factor of the complement system. Conclusion: The results obtained in the scientific and practical aspect are of interest for understanding the etiopathogenesis of diabetic retinopathy and can be used in the development of treatment methods for this disease.</p></abstract><trans-abstract xml:lang="en"><p>Background: In the elderly, diabetic retinopathy causes a significant deterioration in the functional activity and quality of life of patients, but the individual mechanisms of its development and, in particular, the influence of the components of the blood complement system remain insufficiently studied. The aim of the study: To analyze the features of the blood complement system in elderly patients with diabetic retinopathy. Materials and methods: The components of the blood complement system were studied in 78 patients aged 60-74 years with diabetic retinopathy (the main group) at the Tambov branch of the Academician S. N. Fedorov Eye Microsurgery Research Institute by means of an enzyme immunoassay and a hemolytic method using a commercial ELISA kit (UK). The control group consisted of 46 patients aged 60-74 years without diabetic retinopathy, in whom the blood complement system was similarly examined. To identify the leading components of the blood complement system that contribute to the development of diabetic. Results: In elderly patients with diabetic retinopathy, there was a significant and statistically significant increase in serum C3a components of the complement system to 145.9&amp;plusmn;4.3 ng/ml versus 43.1&amp;plusmn;3.8 ng/ml in the control group, C5a components to 6.8&amp;plusmn;0.4 ng/ml versus 3.2&amp;plusmn;0.2 ng/ml, respectively, factor H to 262.3&amp;plusmn;5.0 mcg/ml versus 139.8&amp;plusmn;4.1 mcg/ml. Simultaneously, with the development of diabetic retinopathy, a decrease in C1-ing components was observed. In accordance with the values of the odds ratio, the leading components of the blood complement system that determine the formation of diabetic retinopathy in old age are the C3a component, C5a component, and the H factor of the complement system. Conclusion: The results obtained in the scientific and practical aspect are of interest for understanding the etiopathogenesis of diabetic retinopathy and can be used in the development of treatment methods for this disease.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>diabetic retinopathy</kwd><kwd>elderly age</kwd><kwd>blood complement system</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetic retinopathy</kwd><kwd>elderly age</kwd><kwd>blood complement system</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI insight. 2017;2(14):e93751. DOI: https://doi.org/10.1172/jci.insight.93751</mixed-citation></ref><ref id="B2"><mixed-citation>Chen M, Xu H. Parainflammation, chronic inflammation, and age-related macular degeneration. Journal of Leukocyte Biology. 2015;98(5):713-725.</mixed-citation></ref><ref id="B3"><mixed-citation>Mukai R, Okunuki Y, Husain D, et al. The Complement System Is Critical in Maintaining Retinal Integrity during Aging. Frontiers in Aging Neuroscience. 2018;10:15. DOI: https://doi.org/10.3389/fnagi.2018.00015</mixed-citation></ref><ref id="B4"><mixed-citation>Mandava N, Tirado-Gonzalez V, Geiger MD, et al. Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy. Investigative Ophthalmology and Visual Science. 2020;61(11):39.</mixed-citation></ref><ref id="B5"><mixed-citation>Solomon SD, Chew E, Duh EJ, et al. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(3):412-418. DOI: https://doi.org/10.2337/dc16-2641</mixed-citation></ref><ref id="B6"><mixed-citation>Rubsam A, Parikh S, Fort PE. Role of Inflammation in Diabetic Retinopathy. International Journal of Molecular Sciences. 2018;19(4):942.</mixed-citation></ref><ref id="B7"><mixed-citation>Clark SJ, Bishop PN. The eye as a complement dysregulation hotspot. Seminars in Immunopathology. 2018;40(1):65-74. DOI: https://doi.org/10.1007/s00281-017-0649-6</mixed-citation></ref><ref id="B8"><mixed-citation>Akhtar-Schafer I, Wang L, Krohne TU, et al. Modulation of three key innate immune pathways for the most common retinal degenerative diseases. EMBO Molecular Medicine. 2018;10(10):e8259. DOI: https://doi.org/10.15252/emmm.201708259</mixed-citation></ref><ref id="B9"><mixed-citation>Balaiya S, Zhou Z, Chalam KV. Characterization of Vitreous and Aqueous Proteome in Humans With Proliferative Diabetic Retinopathy and Its Clinical Correlation. Proteomics Insights. 2017;8:1178641816686078. DOI: https://doi.org/10.1177/1178641816686078</mixed-citation></ref><ref id="B10"><mixed-citation>Schori С, Trachsel C, Grossmann J, et al. The Proteomic Landscape in the Vitreous of Patients With Age-Related and Diabetic Retinal Disease. Investigative Ophthalmology and Visual Science. 2018;59(4):AMD31-AMD40. DOI: https://doi.org/10.1167/iovs.18-24122</mixed-citation></ref><ref id="B11"><mixed-citation>Shahulhameed S, Vishwakarma S, Chhablani J, et al. A Systematic Investigation on Complement Pathway Activation in Diabetic Retinopathy. Frontiers in Immunology. 2020;11:154. DOI: https://doi.org/10.3389/fimmu.2020.00154</mixed-citation></ref><ref id="B12"><mixed-citation>Li J, Li Q, Li P. Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy. BMC Ophthalmology. 2018;18(1):151.</mixed-citation></ref><ref id="B13"><mixed-citation>Kim K, Kim ES, Kim DG, et al. Progressive retinal neurodegeneration and microvascular change in diabetic retinopathy: longitudinal study using OCT angiography. Acta Diabetologica. 2019;56(12):1275-1282. DOI: https://doi.org/10.1007/s00592-019-01395-6</mixed-citation></ref><ref id="B14"><mixed-citation>Keir LS, Firth R, Aponik L, et al. VEGF regulates local inhibitory complement proteins in the eye and kidney. Journal of Clinical Investigation. 2017;127(1):199-214. DOI: https://doi.org/10.1172/JCI86418</mixed-citation></ref></ref-list></back></article>